LOGO
LOGO

Political News

Romney Continues March To Inevitable Nomination

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Former Massachusetts governor Mitt Romney picked up two more Republican primary victories on Tuesday, claiming the GOP contests in Arkansas and Kentucky.

Both outcomes were widely expected, as Romney is already the GOP's presumptive nominee with no active competition for the party's nod for the presidential election in November against Barack Obama.

Heading into the day's action, Romney had 989 delegates. Former Pennsylvania senator Rick Santorum was a distant second with 259, followed by former Speaker of the House Newt Gingrich at 141 and Texas congressman Ron Paul at 108 - although those last three have all suspended their campaigns in the face of certain defeat.

Romney had approximately 70 percent of the vote in both states.

There are 42 delegates up for grabs in Kentucky, plus 33 in Arkansas as Romney edges ever closer to the magic clinching number of 1,144 to officially claim his party's nomination.

Romney can clinch on May 29 in the Texas primary, which has 155 delegates at stake.

After Texas, there are primaries in California, Montana, New Jersey, New Mexico and South Dakota on June 5. Then primary season comes to an end on June 26 in Utah.

The Republican National Convention is August 27 to 30 in Tampa.

For comments and feedback contact: editorial@rttnews.com

Political News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19